Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0234 Transporter Info
Gene Name SLC26A6
Transporter Name Anion exchange transporter
Gene ID
65010
UniProt ID
Q9BXS9
Microbiota Influence of This DT (MBI)

Bacteria: Bacillota

   Genus: Lacticaseibacillus

     Lacticaseibacillus casei 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence 1

 Up regulating of SLC26A6 expression in type 2 diabetes mellitus condition [1]

Studied Phenotype

 Type 2 diabetes mellitus [ICD11: 5A11]

Studied Tissue

 Kidney

In Vivo Model

 Sprague-Dawley rats

Detailed Description

 The Lacticaseibacillus casei str. Zhang has been reported to increase the expression of the drug transporter SLC26A6.

Bacteria: Host unspecified microbiota

   Genus: Unknown microbiota

     Host unspecified microbiota 

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence 1

 Down regulating of SLC26A6 expression in urinary stone disease condition [2] , [3]

Studied Phenotype

 Urinary stone disease [ICD111: GB71.0]

Studied Tissue

 Kidney

In Vivo Model

 C57BL/6N mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC26A6.

       Microbe Influence 2

 Down regulating of SLC26A6 expression in urinary stone disease condition [2] , [3]

Studied Phenotype

 Urinary stone disease [ICD111: GB71.0]

Studied Tissue

 Colon

In Vivo Model

 C57BL/6N mice

Detailed Description

 The host unspecified microbiota has been reported to decrease the expression of the drug transporter SLC26A6.

       Microbe Influence 3

 Up regulating of SLC26A6 expression in urinary stone disease condition [2] , [3]

Studied Phenotype

 Urinary stone disease [ICD111: GB71.0]

Studied Tissue

 Caecum

In Vivo Model

 C57BL/6N mice

Detailed Description

 The host unspecified microbiota has been reported to increase the expression of the drug transporter SLC26A6.
References
1 Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx. Sci Rep. 2014 Jul 18;4:5654.
2 Mechanisms of the intestinal and urinary microbiome in kidney stone disease. Nat Rev Urol. 2022 Dec;19(12):695-707.
3 Fecal transplant modifies urine chemistry risk factors for urinary stone disease. Physiol Rep. 2019 Feb;7(4):e14012.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.